Home » Topics » Regulatory » Patents

Patents
RSS

Peptidomimetic aspartyl protease inhibitors from Pharmacopeia for AD and malaria

Feb. 22, 1999

Structurally novel antiinflammatory/antiallergic agents in the Astra pipeline

Feb. 22, 1999

Polyol anti-Helicobacter pylori agents, compositions and use claimed by Takeda

Feb. 22, 1999

Boehringer Ingelheim researches thrombin inhibitors

Feb. 19, 1999

Protein farnesyltransferase inhibitors in development at Bristol-Myers Squibb

Feb. 19, 1999

Potent bradykinin antagonists developed at Fournier

Feb. 19, 1999

Dopamine D4-selective compounds, therapeutic and diagnostic uses disclosed by Resolution

Feb. 19, 1999

Roche discloses inhibitors of TNF-alpha/TGF-alpha release, keratinocyte proliferation

Feb. 18, 1999

Patent covers new ADIR compounds with high affinity for imidazoline receptors

Feb. 18, 1999

More from SmithKline Beecham on p38 MAP kinase inhibitors

Feb. 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...